SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 210 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $355,000 | -25.3% | 25,000 | 0.0% | 0.01% | -30.8% |
| Q1 2018 | $475,000 | +47400.0% | 25,000 | +9091.2% | 0.01% | – |
| Q4 2016 | $1,000 | 0.0% | 272 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | -100.0% | 272 | -100.0% | 0.00% | -100.0% |
| Q2 2015 | $8,872,000 | -29.3% | 800,000 | 0.0% | 0.53% | -45.2% |
| Q1 2015 | $12,544,000 | +3.1% | 800,000 | 0.0% | 0.98% | -4.4% |
| Q4 2014 | $12,168,000 | +41.0% | 800,000 | 0.0% | 1.02% | +10.2% |
| Q3 2014 | $8,628,000 | -29.4% | 800,000 | 0.0% | 0.93% | -22.7% |
| Q2 2014 | $12,216,000 | -15.5% | 800,000 | 0.0% | 1.20% | -21.2% |
| Q1 2014 | $14,464,000 | -28.6% | 800,000 | -58.5% | 1.52% | +82.5% |
| Q3 2013 | $20,246,000 | – | 1,930,000 | – | 0.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |